HOLX - Hologic Inc Stock Price, Fair Value and News

78.65USD+0.77 (+0.99%)Market Closed

Market Summary

USD78.65+0.77

Market Closed

0.99%

HOLX Alerts

2 major insider sales recently.

HOLX Stock Price

View Fullscreen

HOLX RSI Chart

HOLX Valuation

Market Cap

18.4B

Price/Earnings (Trailing)

39.35

Price/Sales (Trailing)

4.63

EV/EBITDA

24.19

Price/Free Cashflow

16.63

HOLX Price/Sales (Trailing)

HOLX Profitability

EBT Margin

14.15%

Return on Equity

9.63%

Return on Assets

5.35%

Free Cashflow Yield

6.01%

HOLX Fundamentals

HOLX Revenue

Revenue (TTM)

4.0B

Rev. Growth (Yr)

-0.85%

Rev. Growth (Qtr)

0.46%

HOLX Earnings

Earnings (TTM)

466.5M

Earnings Growth (Yr)

-22.24%

Earnings Growth (Qtr)

-31.08%

Breaking Down HOLX Revenue

Last 7 days

0.7%

Last 30 days

8.8%

Last 90 days

3.5%

Trailing 12 Months

-2.2%

How does HOLX drawdown profile look like?

HOLX Financial Health

Current Ratio

3.97

Debt/Equity

0.52

Debt/Cashflow

0.44

HOLX Investor Care

Buy Backs (1Y)

5.18%

Diluted EPS (TTM)

1.96

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	4.0B	0	0	0
2023	4.1B	4.0B	4.0B	4.0B
2022	5.4B	5.2B	4.9B	4.5B
2021	5.3B	5.7B	5.6B	5.5B
2020	3.3B	3.3B	3.8B	4.5B
2019	3.3B	3.3B	3.4B	3.4B
2018	2.1B	2.8B	3.2B	3.3B
2017	2.9B	2.3B	2.0B	2.1B
2016	2.8B	2.8B	2.8B	0
2015	2.6B	2.7B	2.7B	2.7B
2014	2.5B	2.5B	2.5B	2.6B
2013	2.3B	2.5B	2.5B	2.5B
2012	1.9B	1.9B	2.0B	2.2B
2011	1.1B	1.5B	1.8B	1.8B
2010	1.4B	1.1B	819.1M	839.2M
2009	1.7B	1.6B	1.6B	1.6B
2008	0	1.2B	1.7B	1.7B
2007	0	0	738.4M	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Hologic Inc

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

CEO	Mr. Stephen P. MacMillan
WEBSITE	hologic.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	6944

Hologic Inc Frequently Asked Questions

What is the ticker symbol for Hologic Inc? What does HOLX stand for in stocks?

HOLX is the stock ticker symbol of Hologic Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hologic Inc (HOLX)?

As of Fri Jul 26 2024, market cap of Hologic Inc is 18.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HOLX stock?

You can check HOLX's fair value in chart for subscribers.

Is Hologic Inc a good stock to buy?

The fair value guage provides a quick view whether HOLX is over valued or under valued. Whether Hologic Inc is cheap or expensive depends on the assumptions which impact Hologic Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HOLX.

What is Hologic Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, HOLX's PE ratio (Price to Earnings) is 39.35 and Price to Sales (PS) ratio is 4.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HOLX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Hologic Inc's stock?

In the past 10 years, Hologic Inc has provided 0.119 (multiply by 100 for percentage) rate of return.